Tru-D Hires Alice Brewer as Director of Clinical Affairs
Tru-D SmartUVC, a leader in the ultraviolet (UV) disinfection space, has hired a Director of Clinical Affairs. Alice Brewer, CIC, has joined the Tru-D team to expand the success of the company’s approach to enhanced UV disinfection throughout the U.S. As Director of Clinical Affairs, Brewer will lead the design and implementation of successful infection reduction programs that highlight Tru-D’s contribution towards meeting hospital objectives and infection rate reduction goals.
“Most recently, Alice served as the Director of Infection Prevention for a large, multi-hospital health system in Wisconsin where, through utilization of robust analytics and innovative strategies, she led a 70 percent reduction of HAIs across the health system,” said Chuck Dunn, CEO and President of Tru-D SmartUVC. “Her experience in creating successful HAI reduction programs combined with her extensive background and knowledge of the field of epidemiology will help our team provide comprehensive disinfection strategies to our hospital partners.”
Brewer has spent 10 years as an epidemiologist in both the pharmaceutical industry and health care. Brewer earned a Bachelor’s degree in Molecular Biology from the University of North Carolina and a Master’s degree in Epidemiology from Indiana University School of Medicine. In 2016, she achieved CIC certification in Infection Control and Epidemiology. She also has a record of publications and presentations in the fields of infectious disease and epidemiological research methodology.
“Infection prevention has been a focus of mine for many years,” said Brewer. “I look forward to bringing my experience in epidemiology and creating successful infection prevention programs to the Tru-D team and working with hospitals to achieve their HAI reduction goals.”
Used in conjunction with manual cleaning protocols, Tru-D is brought in to a hospital room after traditional cleaning is completed. Using chemical-free UVC energy, Tru-D operates from a single position and administers a single cycle of UV light, minimizing additional labor costs and maximizing productivity for the staff. Through the use of its patented Sensor360 technology, Tru-D analyzes the space including size, shape and contents, to deliver a precise, lethal dose of UV light, achieving significant pathogen reduction in the room. Validated by a dozen independent studies as well as the first and only randomized clinical trial on UV disinfection, Tru-D is on a mission to eradicate HAIs and improve patient outcomes.